In a report released today, David Saxon from Needham maintained a Hold rating on ZimVie Inc (ZIMV – Research Report). The company’s shares closed yesterday at $15.38.
Saxon covers the Healthcare sector, focusing on stocks such as Alphatec Holdings, Azenta, and Staar Surgical. According to TipRanks, Saxon has an average return of 3.8% and a 34.41% success rate on recommended stocks.
Currently, the analyst consensus on ZimVie Inc is a Moderate Sell with an average price target of $16.00.
ZIMV market cap is currently $416.5M and has a P/E ratio of -1.05.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
ZimVie Inc (ZIMV) Company Description:
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions.
